Literature DB >> 6816595

Human progastricsin. Analysis of intermediates during activation into gastricsin and determination of the amino acid sequence of the propart.

B Foltmann, A L Jensen.   

Abstract

Human progastricsin was prepared from extracts of gastric mucosa by chromatography on columns of DEAE-cellulose. The amino acid compositions of progastricsin and gastricsin were determined and calculated on the basis of the molecular weights 38 000 and 32 000 respectively. The activation of progastricsin at pH 2 was investigated and monitored by agarose gel electrophoresis at pH 5.4. Two intermediates were observed. Determination of the amino acid sequence showed that the propart consists of 43 amino acid residues. A pronounced homology with other gastric zymogens was found. With the proenzyme amino acid residue numbering used previously [B. Foltman (1981) Essays in Biochemistry, 17, 52-84] the activation of progastricsin at pH 2 may be summarized as follows. The first cleavage occurs after Phe (p27). At pH 5.4 the peptide remains associated with the protein (intermediate I). Subsequent proteolysis removes the peptides from Leu (p28) to Leu (p45). At pH 5.4 the N-terminal peptide from progastricsin (p2-p27) remains associated with gastricsin (intermediate II) until the propart peptide is hydrolysed to smaller fragments.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6816595

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

Review 1.  Structural aspects of activation pathways of aspartic protease zymogens and viral 3C protease precursors.

Authors:  A R Khan; N Khazanovich-Bernstein; E M Bergmann; M N James
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

Review 2.  Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes.

Authors:  A R Khan; M N James
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

3.  Molecular cloning of a pair of human pepsinogen A genes which differ by a Glu----Lys mutation in the activation peptide.

Authors:  M P Evers; B Zelle; D S Peeper; W H Mager; R J Planta; A W Eriksson; R R Frants
Journal:  Hum Genet       Date:  1987-10       Impact factor: 4.132

4.  Variable numbers of pepsinogen genes are located in the centromeric region of human chromosome 11 and determine the high-frequency electrophoretic polymorphism.

Authors:  R T Taggart; T K Mohandas; T B Shows; G I Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

5.  Assignment of human pepsinogen A locus to the q12-pter region of chromosome 11.

Authors:  B Zelle; A Geurts van Kessel; J de Wit; P Evers; F Arwert; J C Pronk; W H Mager; R J Planta; A W Eriksson; R R Frants
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

6.  Demonstration of pepsinogen C in human pancreatic islets.

Authors:  P B Szecsi; H Halgreen; S S Poulsen; C K Axelsson; M Damkjaer-Nielsen; T Kjaer; B Foltmann
Journal:  Gut       Date:  1987-10       Impact factor: 23.059

Review 7.  Mechanism of activation of the gastric aspartic proteinases: pepsinogen, progastricsin and prochymosin.

Authors:  C Richter; T Tanaka; R Y Yada
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

8.  Molecular mechanisms of Wischnewski spot development on gastric mucosa in fatal hypothermia: an experimental study in rats.

Authors:  Chihpin Yang; Kana Sugimoto; Yukie Murata; Yuichiro Hirata; Yu Kamakura; Yoshihisa Koyama; Yohei Miyashita; Kentaro Nakama; Kazuma Higashisaka; Kazuo Harada; Ryuichi Katada; Hiroshi Matsumoto
Journal:  Sci Rep       Date:  2020-02-05       Impact factor: 4.379

9.  Expression of pepsinogen C in human breast tumours and correlation with clinicopathologic parameters.

Authors:  I Diez-Itza; A M Merino; J Tolivia; F Vizoso; L M Sánchez; C López-Otín
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.